Editorial Bitar, Kattan, Kourie, Mukherji & Saghir We suggest different strategies in various settings to take care of cancer patients based on their disease stage and the treatment they have received (curative vs palliative) [5] . The detailed suggested strategy for patients on follow-up or on endocrine/nonimmunopressive oral targeted therapies who can be managed at home, patients with early stage cancer/curative setting and patients with metastatic disease are summarized in the Table 1. The prevention advice for patients consist of avoiding crowded places, washing hands according to WHO recommendations, using sanitizers and gloves, wearing masks properly when going to clinic/hospital. Moreover, cancer patients should not have any contact with family and friends with COVID-19 symptoms/possible exposure and should practice social distancing with all people to protect themselves and others. Finally, patients should remain in contact with their medical team and report new symptoms by telephone first (fever/cough/shortness of breath) [6] .
As the situation changes, each center will be required to face unique ethical issues regarding allocation of resources, balancing the unknown risks of treatment versus benefits and measures taken to ensure the safety of patients, family members and staff. National and regional professional societies have a key role to play in disseminating best practice based on evidence as it emerges.
To conclude, COVID-19 pandemic represents a historical cancer care challenge for our oncology community. Preventive measures by the oncology staff, clinics, departments and patients themselves are necessary to decrease the number of infected cancer patients by COVID-19. General recommendations from local oncology societies with strategies for rapid communication of new data are mandatory to assure the best care for cancer patients during this COVID-19 pandemic.
